About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
The Moran Company conducted an analysis of the 2022 Medicare Part B Quarterly Average Sales Price (ASP) Pricing File published by the Centers for Medicare and Medicaid Services (CMS), which contains the payment amounts used to pay for Part B covered medicines and biologics. The analysis includes the top 50 Part B medicines by total spending in 2020 that have ASP data in 2022. The purpose of this analysis was to replicate the CMS analysis of the trend in ASPs in the file and to determine the drivers of reductions in ASP.